Sixth Element Capital is currently managing the £70m CRT Pioneer Fund (CPF) to create the future of cancer therapy and diagnosis.
Investment Type: Venture Capital
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 16.11.2017 | NeoPhore R... | NeoPhore Ltd, a spin out from ... | UK | - | finsmes.co... |
| 09.04.2012 | EIF and Ca... | European Investment Fund and C... | funding S... | - | finsmes.co... |